metricas
covid
Buscar en
Revista Iberoamericana de Micología
Toda la web
Inicio Revista Iberoamericana de Micología Ventriculoperitoneal shunt infection by Cryptococcus neoformans sensu stricto: C...
Journal Information
Vol. 39. Issue 1.
Pages 16-20 (January - March 2022)
Share
Share
Download PDF
More article options
Visits
1599
Vol. 39. Issue 1.
Pages 16-20 (January - March 2022)
Note
Full text access
Ventriculoperitoneal shunt infection by Cryptococcus neoformans sensu stricto: Case report and literature review
Infección por Cryptococcus neoformans sensu stricto en paciente con derivación ventriculoperitoneal
Visits
1599
Anil Kumara,
Corresponding author
vanilkumar@aims.amrita.edu

Corresponding author.
, Suhas Udayakumaranb, Arun Sachuc, Nandita Shashindrana, Poornima Babya, Ameena Thahaa, Anna Kuriena, Anuradha Chowdharyd
a Department of Microbiology, Amrita Institute of Medical Sciences & Research Centre, Amrita Vishwa Vidyapeetham, Ponekara, Kochi, Kerala, India
b Department of Neurosurgery, Amrita Institute of Medical Sciences & Research Centre, Amrita Vishwa Vidyapeetham, Ponekara, Kochi, Kerala, India
c Department of Microbiology, Believers Church Medical College, Thiruvalla, Kerala, India
d Department of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (4)
Show moreShow less
Tables (1)
Table 1. Clinical details of previously reported cases of cryptococcal shunt infections and the current case.
Abstract
Background

Cryptococcal ventriculoperitoneal shunt infection is known to occur due to an underlying infection in the patient rather than by nosocomial transmission of Cryptococcus during shunt placement. A case of chronic hydrocephalus due to cryptococcal meningitis that was misdiagnosed as tuberculous meningitis is described.

Case report

Patient details were extracted from charts and laboratory records. The identification of the isolate was confirmed by PCR-restriction fragment length polymorphism of the orotodine monophosphate pyrophosphorylase (URA5) gene. Antifungal susceptibility was determined using the CLSI M27-A3 broth microdilution method. Besides, a Medline search was performed to review all cases of Cryptococcus ventriculoperitoneal shunt infection. Cryptococcus neoformans sensu stricto (formerly Cryptococcus neoformans var. grubii), mating-type MATα was isolated from the cerebrospinal fluid and external ventricular drain tip. The isolate showed low minimum inhibitory concentrations for voriconazole (0.06mg/l), fluconazole (8mg/l), isavuconazole (<0.015mg/l), posaconazole (<0.03mg/l), amphotericin B (<0.06mg/l) and 5-fluorocytosine (1mg/l). The patient was treated with intravenous amphotericin B deoxycholate, but died of cardiopulmonary arrest on the fifteenth postoperative day.

Conclusions

This report underlines the need to rule out a Cryptococcus infection in those cases of chronic meningitis with hydrocephalus.

Keywords:
Cryptococcus neoformans sensu stricto
Cryptococcus deneoformans
Cryptococcus neoformans var. grubii
Ventriculoperitoneal shunt
Tuberculosis
Diabetes
Infection
Resumen
Antecedentes

La infección criptocócica por contaminación de las derivaciones ventriculoperitoneales es una complicación que puede tener lugar en el paciente previamente infectado más que deberse a una transmisión nosocomial de Cryptococcus durante la colocación del dispositivo. Se describe un caso de hidrocefalia crónica por meningitis criptocócica que se diagnosticó erróneamente como meningitis tuberculosa.

Caso clínico

Los datos del paciente se extrajeron de la historia clínica y de los registros de laboratorio. La identificación del aislamiento se confirmó mediante PCR de polimorfismo de longitud de fragmento de restricción del gen de la orotodina monofosfato pirofosforilasa (URA5). La sensibilidad a los antifúngicos se realizó mediante el método de microdilución en caldo CLSI M27-A3. Se realizó, además, una búsqueda en Medline para revisar todos los casos de infección por Cryptococcus asociados a derivación ventriculoperitoneal. Se aisló Cryptococcus neoformans sensu stricto (antes Cryptococcus neoformans var. grubii), tipo MATα, del líquido cefalorraquídeo y de la punta del drenaje extraventricular. El aislamiento mostró, in vitro, valores bajos de concentración mínima inhibitoria para el voriconazol (0,06mg/l), el fluconazol (8mg/l), el isavuconazol (<0,015mg/l), el posaconazol (<0,03mg/l), la anfotericina B (<0,06mg/l) y la 5-fluorocitocina (1mg/l). El paciente fue tratado con anfotericina B desoxicolato intravenoso, pero falleció por parada cardiopulmonar el decimoquinto día del postoperatorio.

Conclusiones

Nuestro caso subraya la necesidad de descartar la presencia de Cryptococcus en los casos de meningitis crónica con hidrocefalia.

Palabras clave:
Cryptococcus neoformans sensu stricto
Cryptococcus deneoformans
Cryptococcus neoformans var. grubii
Derivación ventriculoperitoneal
Tuberculosis
Diabetes
Infección
Full Text

Cryptococcosis is an invasive fungal infection with an increasing prevalence in immunocompromised hosts.17 The two varieties within Cryptococcus neoformans were raised to the species level in 2015 — Cryptococcus neoformans var. grubii as Cryptococcus neoformans sensu stricto, and Cryptococcus neoformans var. neoformans as Cryptococcus deneoformans.11 Furthermore, five species within the Cryptococcus gattii species complex were identified. The decayed wood of several trees worldwide is the main environmental niche for the Cryptococcus neoformans species complex.17

C. neoformans and C. deneoformans typically infect people with human immunodeficiency virus (HIV), while the C. gattii complex causes disease in apparently healthy individuals.8,11 Cryptococcal infections also occur in immunodeficient hosts with diabetes, cancer, haematological malignancies, solid organ transplant, sarcoidosis, autoimmune hemolytic anemia, and long-term steroid therapy. Clinically and radiologically, systemic cryptococcosis can masquerade as tuberculosis. In countries such as India, where tuberculosis is hyperendemic, cryptococcal meningitis is not considered in cases of chronic meningitis and, by default, patients are treated for tuberculous meningitis. Conditions such as brain tumor, cerebral stroke, and enteric fever can mimic cryptococcal meningitis.12,14 It also must be distinguised from pyogenic and aseptic meningitis. Untreated cryptococcal meningitis is fatal. Ventriculoperitoneal (VP) shunt placement complicated by cryptococcal infection has rarely been reported.

Case report

We present the case of a 58-year-old man with diabetes, treated for two years due to chronic hydrocephalus, supposedly ensuing from tuberculous meningitis, with a VP shunt. He had a history of multiple VP shunt revisions with no improvement, and was referred to the Amrita Institute for further management. Computed tomography of the head showed the presence of the shunt in situ and a defect of the previous craniotomy (Fig. 1), dilatation of the lateral, third, and fourth ventricles, and periventricular hypointensities with no evidence of bleeding. Magnetic resonance imaging with contrast of the brain showed gross hydrocephalus, ependymal enhancement along the occipital horn and the fourth ventricle (suggestive of ependymitis), and no evidence of focal enhancing lesions (Fig. 2). Hematological examination revealed microcytic hypochromic anemia and a leukocyte count of 17,900cells/μl (87% polymorphonuclear leukocytes). Cortisol concentration was 24μg/dl, C-reactive protein 250 mg/l, HbA1c 8.6%, fasting glucose concentration 170 mg/dl, hemoglobin 13.8g/dl, platelet count 372K/μl, and erythrocyte sedimentation rate 34mm/h. The serological tests for HIV, hepatitis B virus, and hepatitis C were negative. Liver, renal, and thyroid function tests were unremarkable. Cerebrospinal fluid (CSF) analysis showed 5leucocytes/μl, glucose 98mg/dl, and protein 250mg/dl. The patient underwent a surgical procedure to insert a long-tunneled external ventricular drainage on the right side of the brain and to remove the previous shunt. Cultures of the CSF and the external ventricular drain tip showed the growth of Cryptococcus sp., based on its pigmentation on niger seed agar (Fig. 3) and the observation of encapsulated budding yeast cells under the microscope (Fig. 4). CSF smears for acid-fast bacilli and cultures of mycobacteria were negative. The blood cultures were negative. The two isolates recovered were identified as Cryptococcus neoformans with 95% probability using the automated VITEK 2 compact system using the YST card (bioMérieux, Marcy-l’Etoile, France). In order to ensure the identification, a molecular typing technique, using polymerase chain reaction (PCR)-restriction fragment length polymorphism of the URA5 gene, was performed to both the isolates from the CSF and the drainage tip,16 comparing the banding pattern obtained with those of reference isolates. The isolates showed the molecular type VNI (serotype A). Serotyping and mating types were analyzed by PCR of the STE20 and STE12 genes.16 The isolates showed only one band of approximately 588 bp, specific for STE20Aα, confirming that the isolates were C. neoformans sensu stricto, mating type MATα. Antifungal susceptibility was determined using the broth microdilution method according to the Clinical and Laboratory Standards Institute M27-A3 recommendations.2 The isolate showed low minimum inhibitory concentrations, below epidemiological cut-off values, for voriconazole (0.06μg/ml), fluconazole (8μg/ml), isavuconazole (<0.015μg/ml), posaconazole (<0.03μg/ml), amphotericin B (<0.06μg/ml), and 5-fluorocytosine (1μg/ml).6,7 The patient was treated with intravenous amphotericin B deoxycholate, but died of cardiopulmonary arrest on the fifteenth postoperative day.

Fig. 1.

CT brain scan showing hydrocephalus and extra-ventricular drain in situ.

(0.07MB).
Fig. 2.

Axial T2 MR image showing evidence of active hydrocephalus with periventricular lucency. Abnormal hypointense lining was seen at the occipital horn corresponding to the enhancement in the post contrast scans.

(0.09MB).
Fig. 3.

Chocolate brown yeast-like colonies of Cryptococcus neoformans sensu stricto on niger seed (Guizotia abyssinica) medium, isolated from the CSF after 72h of incubation at 28°C.

(0.07MB).
Fig. 4.

India ink mount showing encapsulated spherical, budding yeast cells of Cryptococcus neoformans sensu stricto isolated from the CSF sediment (1000×).

(0.04MB).
Discussion

The estimated incidence of cryptococcal meningitis cases in India and Southeast Asia is approximately 120,000 or 3% per year, with a mortality of 20%–50%.18 A recent study from India found that the prevalence of cryptococcal antigenemia in HIV-infected adults with CD4 counts below 100cells/mm3 was 8%.18 In non-HIV-infected and immunocompetent patients cryptococcosis is rarely suspected, and treatment is started only when the patient does not improve with antibacterial or antitubercular drugs. The study of CSF in the laboratory by means of fungal culture, India ink preparation, and latex agglutination test for cryptococcal antigen, is invaluable for making a correct diagnosis. The CrAg latex agglutination test has been reported as 100% sensitive and specific.

Concomitant tuberculosis with cryptococcal meningitis has been reported previously.18 Cryptococcal infections in VP shunts are unusual. Previous studies have described that VP shunts were placed in patients who presented with chronic hydrocephalus, which likely represented a complication of an underlying infection with C. neoformans.12 In the present case, the patient was wrongly diagnosed with tuberculous meningitis. The cryptococcal infection resulted in hydrocephalus before shunt placement. It was neither a de novo infection nor a complication of shunt placement. Among the 16 reported cases of cryptococcal VP shunt infection (Table 1), only in three cases the presence of C. neoformans was confirmed. The majority (88%) of the cases were diagnosed within two years of shunt placement. In three cases in which a cryptococcal infection was diagnosed after more than 20 years after having the shunt placed, the hydrocephalus and the cryptococcal infection may be independent events.5,19 In the other cases, underlying cryptococcal meningitis must have led to hydrocephalus, which was then relieved by the placement of the VP shunt. Thereafter, the silent cryptococcal infection may have led to a shunt infection. Cryptococcal VP shunt infection can also cause abdominal pseudocyst and subcutaneous pseudocyst.19 Both tuberculous and cryptococcal meningitis can lead to hydrocephalus, and VP shunting is a common therapeutic approach to relieve the increased pressure. Infection of the shunt is the most common complication and is caused mostly by bacteria and rarely by Cryptococcus species.

Table 1.

Clinical details of previously reported cases of cryptococcal shunt infections and the current case.

No.  Age/Sex  Underlying disease  Shunt  Time from shunt placement to symptoms  Treatment  Shunt removal  Outcome  CSF analysisAuthor & year 
                WBC (cells/μL)  Protein (mg/dL)  Glucose (mg/dL)  CrAg  Cryptococcus species isolated (according to the new taxonomy)   
22/M  None  VP  1 year  AMB+5FC  Yes  Died  90  71  1:128  C. deneoformans  Mangam et al., 198315
58/M  None  VP  9 months  AMB+5FC  Yes  Survived  43  51  ND  C. deneoformans 
55/M  CLD, DM, NPH  VP  4 months  AMB+5FC  Yes  Died  265  945  127  1:8  C. deneoformans 
NA  Sarcoidosis  VP  Unknown  AMB  Yes  Survived  NA  NA  NA  NA  C. deneoformans  Baallal et al., 19831 
28/M  None  VA  20 years  AMB+5FC  Yes  Died  45  1:32  C. deneoformans  Walsh et al., 198620 
46/F  Small cell cancer  VA  15 months  AMB+5FC  No  Survived  10  25  51  1:8  C. deneoformans  Yadav et al., 198821 
53/M  Sarcoid  VP  52 days  AMB+5FC+FLU  Yes  Survived  438  32  1:1  C. deneoformans  Ingram et al., 199312
35/M  None  VP  26 days  AMB+5FC+FLU  Yes  Survived  120  272  11  1:32  C. deneoformans 
61/M  NPH  VP  38 years  LAMB  No  Died  ND  ND  ND  C. neoformans sensu stricto  Ecvit et al., 20065 
10  46/F  NPH  VP  9 months  AMB+FLU  No  Survived  37  22  1:16  C. neoformans sensu stricto  Gade et al., 20069 
11  34/M  None  VP  1 year  AMB  Yes  Died  ND  267  ND  C. deneoformans  Crum et al., 20083 
12  65/M  NPH  VP  20 years  LAMB+5FC  Yes  Survived  ND  ND  ND  ND  C. deneoformans  Viereck et al., 201419 
13  80/M  NPH  VP  1 year  AMB+5FC  Yes  Survived  304  22  1:256  C. deneoformans  Lee et al., 201614 
14  52/M  NPH  VP  1 year  AMB+5FC+FLU  Yes  Survived  NA  NA  NA  NA  C. deneoformans  Foong et al. 20168 
15  36/F  HIV, TB meningitis  VP  1 year  AMB+5FC+FLU  Yes  Survived  133  6.8  ND  C. deneoformans  Genebat et al., 201710 
16  66/F  HT  VP  2 years  AMB+FLU  Yes  Survived  NA  NA  NA  >1:1024  C. gattii  Dhitinanmuang et al., 20184 
17  58/M  DM  VP  2 years  AMB  Yes  Died  250  98  ND  C. neoformans sensu stricto  Present case 

WBC: white blood cell; VP: ventriculoperitoneal; VA: ventriculoatrial; AMB: amphotericin B deoxycholate; CLD: chronic liver disease; CrAg: cryptococcal antigen; CSF: cerebrospinal fluid; CT: computed tomography; DM: diabetes mellitus; 5FC: 5-fluorocytosine; F: female; FLU: fluconazole; HIV: human immunodeficiency virus; HT: hypertension; LAMB: liposomal amphotericin B; M: male; NPH: normal pressure hydrocephalus; TB tuberculosis; ND: not done; NA: not available.

C. neoformans sensu stricto and C. deneoformans mentioned in the table were reported as C. grubii and C. neoformans in the corresponding articles.

Underlying immunodeficient conditions such as HIV, diabetes mellitus, malignancy, chronic liver disease, and sarcoidosis were identified in six cases of cryptococcal VP shunt infection.13 The majority (83%) of the cases were treated with shunt removal followed by systemic antifungal therapy. Prior culture-proven tuberculous meningitis was documented in only one case,14 and mortality among these patients is as high as 35% despite treatment, which may be due to the advanced stage of the disease as a result of delayed diagnosis. Untreated cryptococcal meningitis is always fatal and needs to be differentiated from other causes of chronic meningitis, such as tuberculous meningitis, especially in countries where mycobacterial infections are endemic.20 Cryptococcal VP shunt infection is a complication of shunt placement in previously infected patients and is not caused by nosocomial transmission of Cryptococcus during placement. Cryptococcal antigen detection is a highly specific and rapid test that should be used with these patients in a previous screening. This report underlines the need to rule out cryptococcal infections in all cases of chronic meningitis with hydrocephalus.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Conflict of interest

The authors declare no conflict of interests.

References
[1]
H. Baallal, A.C. El Asri, B. Eljebbouri, A. Akhaddar, M. Gazzaz, B. El Mostarchid, et al.
Cryptococcal meningitis in a patient with a ventriculoperitoneal shunt and monitoring for pulmonary sarcoidosis.
Neurochirurgie, 59 (2013), pp. 47-49
[2]
CLSI.
Reference method for broth dilution antifungal susceptibility testing of yeasts: 3rd ed. M27-A3.
Clinical and Laboratory Standards Institute, (2008),
[3]
C.P. Crum, P.S. Feldman.
Cryptococcal peritonitis complicating a ventriculoperitoneal shunt in unsuspected cryptococcal meningitis.
Hum Pathol, 12 (1981), pp. 660-663
[4]
W. Dhitinanmuang, P. Chongtrakool, A. Jitmuang.
Undiagnosed Cryptococcus gattii meningitis leading to subsequent ventriculoperitoneal shunt infection in a patient with symptoms of normal pressure hydrocephalus: case report and literature review.
BMC Infect Dis, 18 (2018), pp. 257
[5]
I.Z. Ecevit, C.J. Clancy, I.M. Schmalfuss, M.H. Nguyen.
The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: a call for better disease recognition and evaluation of adjuncts to antifungal therapy.
Clin Infect Dis, 42 (2006), pp. 1443-1447
[6]
A. Espinel-Ingroff, A. Chowdhary, M. Cuenca-Estrella, A. Fothergill, J. Fuller, F. Hagen, et al.
Cryptococcus neoformans–Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine.
Antimicrob Agents Chemother, 56 (2012), pp. 3107-3113
[7]
A. Espinel-Ingroff, A.I. Aller, E. Canton, L.R. Castañón-Olivares, A. Chowdhary, S. Cordoba, et al.
Cryptococcus neoformans–Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
Antimicrob Agents Chemother, 56 (2012), pp. 5898-5906
[8]
K.S. Foong, A. Lee, G. Vasquez.
Cryptococcal infection of the ventriculoperitoneal shunt in an immunocompetent patient.
Am J Case Rep, 17 (2016), pp. 31-34
[9]
R. Gade, G. Turett, E. Stone.
Cryptococcus grubii ventriculoperitoneal shunt infection in an immunocompetent Host (abstract No. 559).
Infectious Diseases Society of America, 44th Annual Meeting,
[10]
M. Genebat, M.J. Mayorga-Buiza, E. Castillo-Ojeda, M. Rivero-Garvía, F.J. Márquez-Rivas, M.E. Jiménez-Mejías.
Cryptococcal infection of the ventriculoperitoneal shunt in an HIV infected patient with an excellent immunovirologic status.
World Neurosurg, 99 (2017), pp. 810
[11]
F. Hagen, K. Khayhan, B. Theelen, A. Kolecka, I. Polacheck, E. Sionov, et al.
Recognition of seven species in the Cryptococcus gattii/Cryptococcus neoformans species complex.
Fungal Genet Biol, 78 (2015), pp. 16-48
[12]
C.W. Ingram, H.B. Haywood 3rd, V.M. Morris, R.L. Allen, J.R. Perfect.
Cryptococcal ventricular-peritoneal shunt infection: clinical and epidemiological evaluation of two closely associated cases.
Infect Control Hosp Epidemiol, 14 (1993), pp. 719-722
[13]
D. Kadam, A. Chandanwale, R. Bharadwaj, N. Nevrekar, S. Joshi, S. Patil, et al.
High prevalence of cryptococcal antigenaemia amongst asymptomatic advanced HIV patients in Pune, India.
Indian J Med Microbiol, 35 (2017), pp. 105-108
[14]
C.H. Lee, K.H. Liao, H.Y. Lin, T.N. Lui, T.Y. Ou, W.S. Lee.
Cryptococcal meningitis complicated with a large abdominal cyst mimicking acute pancreatitis.
J Microbiol Immunol Infect, 49 (2016), pp. 466-467
[15]
D. Mangham, D.N. Gerding, L.R. Peterson, G.A. Sarosi.
Fungal meningitis manifesting as hydrocephalus.
Arch Intern Med, 143 (1983), pp. 728-731
[16]
W. Meyer, A. Castañeda, S. Jackson, M. Huynh, E. Castañeda, IberoAmerican Cryptococcal Study Group.
Molecular typing of Ibero American Cryptococcus neoformans isolates.
Emerg Infect Dis, 9 (2003), pp. 189-195
[17]
A. Prakash, G. Sundar, B. Sharma, F. Hagen, J.F. Meis, A. Chowdhary.
Genotypic diversity in clinical and environmental isolates of Cryptococcus neoformans from India using multilocus microsatellite and multilocus sequence typing.
Mycoses, 63 (2020), pp. 284-293
[18]
D. Rawat, M.R. Capoor, D. Nair, M. Deb, P. Aggarwal.
Concomitant TB and cryptococcosis in HIV-infected patients.
Trop Doct, 38 (2008), pp. 251-252
[19]
M.J. Viereck, N. Chalouhi, D.I. Krieger, K.D. Judy.
Cryptococcal ventriculoperitoneal shunt infection.
J Clin Neurosci, 21 (2014), pp. 2020-2021
[20]
T.J. Walsh, R. Schlegel, M.M. Moody, J.W. Costerton, M. Salcman.
Ventriculoatrial shunt infection due to Cryptococcus neoformans: an ultrastructural and quantitative microbiological study.
Neurosurgery, 18 (1986), pp. 373-375
[21]
S.S. Yadav, J. Perfect, A.H. Friedman.
Successful treatment of cryptococcal ventriculoatrial shunt infection with systemic therapy alone.
Neurosurgery, 23 (1988), pp. 372-373
Copyright © 2022. Asociación Española de Micología
Download PDF
Article options